tiprankstipranks
Bionik Laboratories Corp (BNKL)
OTHER OTC:BNKL
US Market

Bionik Laboratories (BNKL) Financial Statements

10 Followers

Bionik Laboratories Financial Overview

Bionik Laboratories's market cap is currently ―. The company's EPS TTM is $-0.716; its P/E ratio is -0.14; Bionik Laboratories is scheduled to report earnings on February 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 501.11K$ 575.05K$ 486.20K$ 242.83K$ 191.26K
Gross Profit$ 254.12K$ 270.55K$ 297.56K$ 167.65K$ 132.63K
EBIT-$ -1.04M$ -1.11M$ -1.38M$ -1.46M
EBITDA--$ -1.10M$ -1.37M$ -1.44M
Net Income Common Stockholders$ -1.36M$ -1.08M$ -1.13M$ -1.38M$ -1.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 400.00K$ 700.00K$ 397.75K$ 1.33M$ 1.99M
Total Assets$ 3.36M$ 3.69M$ 3.83M$ 4.00M$ 4.68M
Total Debt$ 2.41M$ 1.86M$ 1.04M$ 503.47K$ 0.00
Net Debt$ 2.01M$ 1.16M$ 638.96K$ -825.31K$ -1.99M
Total Liabilities$ 5.00M$ 4.21M$ 3.31M$ 2.41M$ 1.75M
Stockholders Equity$ -1.64M$ -521.91K$ 523.02K$ 1.60M$ 2.93M
Cash Flow-
Free Cash Flow--$ -955.27K$ -1.16M$ -1.38M
Operating Cash Flow$ -756.94K-$ -955.27K$ -1.16M$ -1.38M
Investing Cash Flow$ -752.00-$ -222.18K$ 0.00$ 0.00
Financing Cash Flow$ 500.00K-$ 250.00K$ 500.00K$ 1.44K
Currency in USD

Bionik Laboratories Earnings and Revenue History

Bionik Laboratories Debt to Assets

Bionik Laboratories Cash Flow

Bionik Laboratories Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis